+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pipette Controllers - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • PDF Icon

    Report

  • 110 Pages
  • February 2024
  • Region: Global
  • Mordor Intelligence
  • ID: 5529398
UP TO OFF until Mar 31st 2024
The pipette controllers market is anticipated to register a CAGR of 4.5% over the forecast period.

Key Highlights

  • Research in numerous scientific fields experienced slowdowns due to the COVID-19 pandemic, except for COVID-19-related studies. Yet, significant advancements in COVID-19 detection emerged, particularly using diverse lab equipment, profoundly influencing the market amid the pandemic. As of March 2021, a report by Integra Biosciences highlighted that their Voyager adjustable tip spacing pipette played a pivotal role in aiding research teams to swiftly develop COVID-19 testing kits. These electrical pipettes with better consistency reduce the time for sampling and are likely to increase usage, which is expected to have a significant impact on the market during the pandemic period. The demand for the post-pandemic period is unpredictable due to the decreased cases of COVID-19 and decreased research activities on COVID-19 detection kits.
  • Certain factors that are driving the market growth include increasing R&D activities and the advantages associated with electric pipette controllers. The healthcare industry is observing a huge rise in R&D activities to address several challenges associated with the rising prevalence of various diseases. Globally, the disease burden is shifting from infectious diseases to chronic conditions, with a corresponding escalation in the burden of cancer.
  • Furthermore, the increasing research and development funding likely increases research activities and is expected to propel the market to grow. For instance, as per the European Federation of Pharmaceutical Industries and Associations (EFPIA) report 2022, the pharmaceutical R&D expenditure in Europe is estimated to be EUR 41,500 million (USD 49.07 billion) in 2021, which was compared to EUR 39,656 million (USD 46.84 billion) in the previous year. This shows the increasing R&D expenditure, which is expected to increase the research activities in the pharmaceutical industry and is likely to propel the market over the study period.
  • In addition, the adoption of various pipette controllers in research activities is expected to boost the market. For instance, the report published by Rapid Test Methods Ltd in June 2022 stated that the University of Bayreuth's biophysics research group has been using Integra's Pipetboy acu 2, one of the most widely used pipette controllers, to prepare buffers, media, and samples for its cell culture workflows, streamlining culture set-up, splitting, and media exchange. This adoption of pipette controllers in research studies increases the usage and is expected to have significant growth in the market over the forecast period.
  • However, the lack of skilled personnel is a major hindering factor for the growth of the market over the forecast period.

Pipette Controllers Market Trends

Pharmaceutical Industry Holds Significant Share in the Market Over the Forecast Period

  • The pharmaceutical industry requires sophisticated and well-calibrated equipment to avoid dosage and formulation errors. During the pipetting process of various fluids in pharmaceutical laboratories, pipette controllers are used to maintain the accuracy and consistency of the fluid in all the samples. Disposable pipettes are frequently included with children's medication purchases. Hence, it is expected to have a significant share of the market.
  • The pipette controllers or laboratory pipettors are appropriate for completing pharmaceutical processes such as raw material and final product testing, content uniformity testing, impurity characterization, stability testing and storage, residual solvents testing, sterility testing, and other similar methods. Hence, the new product launches are expected to have significant growth in the market. For instance, in November 2021, Brand Gmbh launched the new pipette controller Accu-Jet S. The new Accu-Jet S from Brand meets both requirements for power and precision and makes work simple, easy, and efficient, which likely propels the market growth.
  • Furthermore, the establishment of new pipette calibration laboratories increases the demand for pipette controllers, which is expected to drive the market. For instance, in June 2022, Eppendorf India inaugurated a Sophisticated Pipette Laboratory and Service Hub (SPLASH) at its facility in Ambattur Industrial Estate, Chennai, India. The facility can calibrate up to 100,000 pipettes in a year. The calibration happens the same way as the pipettes used in the laboratory.
  • Hence, to increase the standards of the pipette for validation in new calibration laboratories, there is an increase in the demand for pipette controllers, which gives accuracy and consistency for the pipettes and boosts the growth of the market over the forecast period.


North America is Expected to have Highest CAGR in the Market Over the Forecat

  • North America is expected to have significant growth in the market and is expected to continue its stronghold over the forecast period. The United States holds the majority of the market in the North American region, owing to the increasing prevalence of chronic diseases. In addition, there is a rise in per capita health expenditure in the country. In addition, continuous progress in R&D to develop technologies that benefit the human race is one of the major driving factors for the pipette controllers market in the region.
  • According to the American Cancer Society's 2023 statistics, there will be an estimated 1,958,310 new cases of cancer in the United States in 2023. Such an increasing burden of new cancer cases increases the demand for new research activities and is likely to propel the usage of pipettes along with pipette controllers in laboratories and is expected to boost the market over the forecast period.
  • Furthermore, the high and increasing research and development activities increase the need for pipette controllers, which is expected to propel the growth of the market. For instance, as per the PhRMA report published in July 2022, PhRMA member firms alone invested USD 102.3 billion in R&D in 2021, the largest amount ever. Hence, the high amount of research funding increases the research activities in the region, which is expected to have a significant impact on the growth of the market over the forecast period.


Pipette Controllers Industry Overview

The pipette controllers market is competitive and consists of a number of major players. Some of the major players in the market include Sartorius AG, Bio-Rad Laboratories, Inc., Avantor, Inc. (VWR International, LLC), Gilson International, and Merck KGaA. The players operating in the market focus on introducing new products to address the changing needs of the pharmaceutical and biotechnology industries.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


This product will be delivered within 2 business days.

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing R&D Activities
4.2.2 Advantages Associated with Electric Pipette Controller
4.3 Market Restraints
4.3.1 Lack of Skilled Personnels
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Type of Product
5.1.1 Manual
5.1.2 Electrical/Battery Powered
5.2 By End-User
5.2.1 Pharmaceutical Industry
5.2.2 Biotechnology Industry
5.2.3 Other End-Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bio-Rad Laboratories, Inc
6.1.2 Drummond Scientific Company
6.1.3 Gilson international
6.1.4 Globe Scientific Inc
6.1.5 Heathrow Scientific
6.1.6 Merck KGaA
6.1.7 Mettler Toledo
6.1.8 Sartorius AG
6.1.9 Avantor, Inc (VWR International, LLC)
6.1.10 Brand GmbH & Co. KG
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Methodology

Loading
LOADING...